Sunbed campaigner acknowledged as one of most influential Australians
17 December 2014
Congratulations to MIA’s Community Co-ordinator, Jay Allen, for being acknowledged on the honour roll of Australia’s most influential people in the non-profit sector.
As a former sunbed user, Jay was diagnosed with stage 3 melanoma in 2008 – a diagnosis that changed his life, turning the former truck driver into a passionate advocate to have sunbeds banned across Australia.
“I started the campaign to ban solariums in Australia in December 2008 because I wasn’t aware of the risks involved when I used them. I didn’t want others to go through what I did by exposing themselves to the harm of these dangerous machines, not knowing the risks associated with them.” Jay says. “With this ban, our future generations will reap the benefits.”
By teaming up with Greens Senator Lee Rhiannon, NSW Greens MP Dr John Kaye, and leading health professor at The University of Sydney Professor Simon Chapman, and together with the support of Melanoma Institute Australia, Jay has ensured the banning of solariums got the attention it deserved.
“I’ve had many meetings with politicians all over Australia sharing my messages about the dangers of solarium use, ran petitions, awareness days, etc.” says Jay. “Persistence has been the key and always speaking from the heart about a real issue that is costing many Australians their life.”
Jay started the campaign that saw sunbeds banned initially in NSW and then throughout Australia. He continues to passionately raise awareness of melanoma and funds for a cure. His campaigning has now moved to New Zealand where he has teamed up with melanoma survivors and key organisations to achieve a ban.
Congratulations to PhD Student, Tuba Nur Gide who was awarded a NSW National Council of Women Australia Day Award for her PhD research work.
Melanoma Institute Australia, is joining forces with the Wollongong Wolves Football Club in the battle to reduce Australia’s melanoma rates.
A new research project will evaluate the benefits and economic implications of CT and PET/CT imaging in patients with asymptomatic Stage III melanoma.
Sunscreen tips for a skin smart summer with the help of Professor Pascale Guitera, Dermatologist Associate for Melanoma Institute Australia.
Although survival rates for people with skin melanoma are increasing, these promises of hope are not being seen in uveal melanoma. Researchers are desperately trying to uncover new ways to treat this disease.
Lucinda Ryan and Carole Renouf talking about melanoma preventation and awareness on 720 ABC Perth.
Research projects led by MIA have been awarded almost $6 million in the latest NHMRC funding round which will enable vital progression of research into melanoma prevention and treatment.
The last decade has seen a surge in therapeutic options for advanced melanoma patients, thanks to research. However, not every patient responds to treatment and researchers are taking on the challenge to find out why.
Our first Global Melanoma Research Report shares selected research from around the world and here at MIA that is making a difference to the lives of melanoma patients now and in the future.
After 18 years as Director of the Sydney Melanoma Unit and then Executive Director of Melanoma Institute Australia, Professor John Thompson AO will step down from the position at the end of 2016.
Australian melanoma clinical practice guidelines have been published on a wiki platform for the first time as researchers try to keep up to date with emerging evidence.
Carole Renouf, CEO of Melanoma Institute Australia is asking young Australians who have been affected by melanoma to share their experiences with her.
Melanoma Institute Australia CEO Carole Renouf wants to make sure Aussies remember to take care of our skin as the festive season draws closer and we spend more time in the sun.
Can an individual’s risk factors for melanoma be used to tailor skin self-examinations and surveillance programs?
Prof Georgina Long has been appointed President-Elect Society for Melanoma Research (SMR).
The Australasian Melanoma Conference is bringing together some of the world's leading researchers and clinicians.
Best practice guidelines for melanoma care have gone digital with the first-ever online guidelines developed to adapt to the rapid change in clinical management.
Congratulations are in order for two of our talented researchers.
Professor Richard Scolyer will be sharing his expertise on melanoma pathology at the upcoming Australasian Melanoma Conference. Here he discusses what he'll be presenting on.
Researchers at MIA have established a High Risk Clinic to monitor people at very high risk of developing melanoma.